Stakeholders now confront the challenge of navigating the HTA review options paper, with its range of complex proposals, but also preparing for the implementation of those accepted by the Albanese Government.
The industry will need to construct a new capability to manage this change
February 2, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
PBS share of health spending on track to halve as Canberra prepares to negotiate with industry
October 26, 2026 - - Latest News -
UTI and contraception care comes to local pharmacies from February
October 26, 2026 - - Latest News -
Documents reveal net PBS spending set to remain on life support to the end of decade
October 26, 2026 - - Latest News -
Health's multi-million dollar rebuild of cost-recovery fees is happening out of view
October 26, 2026 - - Latest News -
There is an urgent need to reconsider the question of PBS sustainability
October 26, 2026 - - Latest News -
Australia leads the way as Moderna and MSD take personalised cancer vaccine into lung cancer
October 24, 2026 - - Latest News -
The private medicines boom has mostly passed vaccines by, for now
October 23, 2026 - - Latest News
